nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—CYP2C9—brain cancer	0.646	1	CbGaD
Pitavastatin—ABCC2—Carboplatin—brain cancer	0.0622	0.239	CbGbCtD
Pitavastatin—ABCG2—Carboplatin—brain cancer	0.0562	0.216	CbGbCtD
Pitavastatin—ABCC2—Etoposide—brain cancer	0.0522	0.201	CbGbCtD
Pitavastatin—ABCG2—Etoposide—brain cancer	0.0472	0.182	CbGbCtD
Pitavastatin—CYP2C8—Etoposide—brain cancer	0.0251	0.0967	CbGbCtD
Pitavastatin—ABCB1—Etoposide—brain cancer	0.017	0.0655	CbGbCtD
Pitavastatin—Rosuvastatin—CYP2C9—brain cancer	0.00245	0.398	CrCbGaD
Pitavastatin—Fluvastatin—CYP2C9—brain cancer	0.00198	0.322	CrCbGaD
Pitavastatin—Atorvastatin—CYP2C9—brain cancer	0.00173	0.28	CrCbGaD
Pitavastatin—SLCO2B1—ganglion—brain cancer	0.00152	0.0661	CbGeAlD
Pitavastatin—Interstitial lung disease—Carmustine—brain cancer	0.00143	0.0305	CcSEcCtD
Pitavastatin—Myopathy—Temozolomide—brain cancer	0.00139	0.0298	CcSEcCtD
Pitavastatin—Interstitial lung disease—Temozolomide—brain cancer	0.00138	0.0295	CcSEcCtD
Pitavastatin—Memory impairment—Temozolomide—brain cancer	0.00124	0.0266	CcSEcCtD
Pitavastatin—Interstitial lung disease—Etoposide—brain cancer	0.0011	0.0236	CcSEcCtD
Pitavastatin—UGT1A3—endocrine gland—brain cancer	0.00103	0.0447	CbGeAlD
Pitavastatin—Hepatic failure—Hydroxyurea—brain cancer	0.00101	0.0216	CcSEcCtD
Pitavastatin—Renal failure acute—Hydroxyurea—brain cancer	0.000983	0.021	CcSEcCtD
Pitavastatin—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00098	0.0542	CbGpPWpGaD
Pitavastatin—UGT2B7—Tamoxifen metabolism—CYP2C9—brain cancer	0.000951	0.0526	CbGpPWpGaD
Pitavastatin—SLCO1B3—pituitary gland—brain cancer	0.000931	0.0406	CbGeAlD
Pitavastatin—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000881	0.0487	CbGpPWpGaD
Pitavastatin—Jaundice—Procarbazine—brain cancer	0.000881	0.0188	CcSEcCtD
Pitavastatin—SLC10A1—gonad—brain cancer	0.000833	0.0363	CbGeAlD
Pitavastatin—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000802	0.0444	CbGpPWpGaD
Pitavastatin—UGT1A3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000799	0.0442	CbGpPWpGaD
Pitavastatin—Hepatic failure—Temozolomide—brain cancer	0.000789	0.0169	CcSEcCtD
Pitavastatin—Amnesia—Carmustine—brain cancer	0.000781	0.0167	CcSEcCtD
Pitavastatin—Amnesia—Temozolomide—brain cancer	0.000754	0.0161	CcSEcCtD
Pitavastatin—SLCO1B3—endocrine gland—brain cancer	0.000721	0.0314	CbGeAlD
Pitavastatin—HMGCR—telencephalon—brain cancer	0.00069	0.0301	CbGeAlD
Pitavastatin—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.000683	0.0378	CbGpPWpGaD
Pitavastatin—HMGCR—SREBF and miR33 in cholesterol and lipid homeostasis—SIRT1—brain cancer	0.000635	0.0352	CbGpPWpGaD
Pitavastatin—SLC10A1—endocrine gland—brain cancer	0.000629	0.0274	CbGeAlD
Pitavastatin—SLC10A1—head—brain cancer	0.000621	0.0271	CbGeAlD
Pitavastatin—Myalgia—Procarbazine—brain cancer	0.000601	0.0128	CcSEcCtD
Pitavastatin—Arthralgia—Procarbazine—brain cancer	0.000601	0.0128	CcSEcCtD
Pitavastatin—UGT2B7—endocrine gland—brain cancer	0.00059	0.0257	CbGeAlD
Pitavastatin—SLCO2B1—telencephalon—brain cancer	0.000585	0.0255	CbGeAlD
Pitavastatin—Confusional state—Procarbazine—brain cancer	0.000581	0.0124	CcSEcCtD
Pitavastatin—HMGCR—gonad—brain cancer	0.000576	0.0251	CbGeAlD
Pitavastatin—SLC10A1—central nervous system—brain cancer	0.000567	0.0247	CbGeAlD
Pitavastatin—Erectile dysfunction—Temozolomide—brain cancer	0.000564	0.0121	CcSEcCtD
Pitavastatin—HMGCR—pituitary gland—brain cancer	0.000562	0.0245	CbGeAlD
Pitavastatin—HMGCR—AMPK Signaling—STRADA—brain cancer	0.000559	0.0309	CbGpPWpGaD
Pitavastatin—SLC10A1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000547	0.0303	CbGpPWpGaD
Pitavastatin—HMGCR—medulla oblongata—brain cancer	0.000543	0.0236	CbGeAlD
Pitavastatin—Nausea—Lomustine—brain cancer	0.000539	0.0115	CcSEcCtD
Pitavastatin—ABCC2—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000538	0.0298	CbGpPWpGaD
Pitavastatin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000525	0.0112	CcSEcCtD
Pitavastatin—Insomnia—Procarbazine—brain cancer	0.000521	0.0111	CcSEcCtD
Pitavastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000513	0.0284	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000507	0.0108	CcSEcCtD
Pitavastatin—Hypoaesthesia—Carmustine—brain cancer	0.000505	0.0108	CcSEcCtD
Pitavastatin—Fatigue—Procarbazine—brain cancer	0.000497	0.0106	CcSEcCtD
Pitavastatin—HMGCR—midbrain—brain cancer	0.000496	0.0216	CbGeAlD
Pitavastatin—Malaise—Hydroxyurea—brain cancer	0.000493	0.0105	CcSEcCtD
Pitavastatin—Constipation—Procarbazine—brain cancer	0.000493	0.0105	CcSEcCtD
Pitavastatin—Hepatitis—Temozolomide—brain cancer	0.00049	0.0105	CcSEcCtD
Pitavastatin—Hypoaesthesia—Temozolomide—brain cancer	0.000488	0.0104	CcSEcCtD
Pitavastatin—HMGCR—spinal cord—brain cancer	0.000484	0.0211	CbGeAlD
Pitavastatin—Feeling abnormal—Procarbazine—brain cancer	0.000475	0.0101	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Procarbazine—brain cancer	0.000471	0.0101	CcSEcCtD
Pitavastatin—SLCO2B1—medulla oblongata—brain cancer	0.00046	0.02	CbGeAlD
Pitavastatin—Discomfort—Hydroxyurea—brain cancer	0.00046	0.00982	CcSEcCtD
Pitavastatin—Urticaria—Procarbazine—brain cancer	0.000458	0.00978	CcSEcCtD
Pitavastatin—Abdominal pain—Procarbazine—brain cancer	0.000455	0.00973	CcSEcCtD
Pitavastatin—SLC10A1—brain—brain cancer	0.00045	0.0196	CbGeAlD
Pitavastatin—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000439	0.0243	CbGpPWpGaD
Pitavastatin—HMGCR—endocrine gland—brain cancer	0.000436	0.019	CbGeAlD
Pitavastatin—HMGCR—head—brain cancer	0.00043	0.0187	CbGeAlD
Pitavastatin—ORM1—spinal cord—brain cancer	0.000428	0.0186	CbGeAlD
Pitavastatin—Back pain—Carmustine—brain cancer	0.000427	0.00913	CcSEcCtD
Pitavastatin—Jaundice—Etoposide—brain cancer	0.000426	0.0091	CcSEcCtD
Pitavastatin—Hypersensitivity—Procarbazine—brain cancer	0.000424	0.00907	CcSEcCtD
Pitavastatin—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000423	0.0234	CbGpPWpGaD
Pitavastatin—SLCO1B1—endocrine gland—brain cancer	0.000417	0.0182	CbGeAlD
Pitavastatin—Asthenia—Procarbazine—brain cancer	0.000413	0.00883	CcSEcCtD
Pitavastatin—Back pain—Temozolomide—brain cancer	0.000413	0.00882	CcSEcCtD
Pitavastatin—SLCO2B1—spinal cord—brain cancer	0.00041	0.0179	CbGeAlD
Pitavastatin—Pruritus—Procarbazine—brain cancer	0.000408	0.00871	CcSEcCtD
Pitavastatin—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000407	0.0225	CbGpPWpGaD
Pitavastatin—Ill-defined disorder—Temozolomide—brain cancer	0.000396	0.00846	CcSEcCtD
Pitavastatin—Diarrhoea—Procarbazine—brain cancer	0.000394	0.00842	CcSEcCtD
Pitavastatin—Dyspepsia—Hydroxyurea—brain cancer	0.000393	0.00839	CcSEcCtD
Pitavastatin—HMGCR—central nervous system—brain cancer	0.000392	0.0171	CbGeAlD
Pitavastatin—Hypoaesthesia—Etoposide—brain cancer	0.00039	0.00834	CcSEcCtD
Pitavastatin—ORM1—endocrine gland—brain cancer	0.000385	0.0168	CbGeAlD
Pitavastatin—Malaise—Temozolomide—brain cancer	0.000385	0.00823	CcSEcCtD
Pitavastatin—Fatigue—Hydroxyurea—brain cancer	0.000384	0.00822	CcSEcCtD
Pitavastatin—HMGCR—cerebellum—brain cancer	0.000384	0.0167	CbGeAlD
Pitavastatin—Constipation—Hydroxyurea—brain cancer	0.000381	0.00815	CcSEcCtD
Pitavastatin—Dizziness—Procarbazine—brain cancer	0.000381	0.00814	CcSEcCtD
Pitavastatin—Myalgia—Carmustine—brain cancer	0.000376	0.00804	CcSEcCtD
Pitavastatin—ABCB1—blood vessel—brain cancer	0.000372	0.0162	CbGeAlD
Pitavastatin—SLCO2B1—endocrine gland—brain cancer	0.000369	0.0161	CbGeAlD
Pitavastatin—Feeling abnormal—Hydroxyurea—brain cancer	0.000367	0.00785	CcSEcCtD
Pitavastatin—ABCG2—telencephalon—brain cancer	0.000366	0.0159	CbGeAlD
Pitavastatin—SLCO2B1—head—brain cancer	0.000364	0.0159	CbGeAlD
Pitavastatin—Confusional state—Carmustine—brain cancer	0.000363	0.00777	CcSEcCtD
Pitavastatin—Arthralgia—Temozolomide—brain cancer	0.000363	0.00777	CcSEcCtD
Pitavastatin—Myalgia—Temozolomide—brain cancer	0.000363	0.00777	CcSEcCtD
Pitavastatin—Rash—Procarbazine—brain cancer	0.000363	0.00776	CcSEcCtD
Pitavastatin—Dermatitis—Procarbazine—brain cancer	0.000363	0.00776	CcSEcCtD
Pitavastatin—Headache—Procarbazine—brain cancer	0.000361	0.00771	CcSEcCtD
Pitavastatin—Discomfort—Temozolomide—brain cancer	0.000359	0.00767	CcSEcCtD
Pitavastatin—Confusional state—Temozolomide—brain cancer	0.000351	0.00751	CcSEcCtD
Pitavastatin—ORM1—central nervous system—brain cancer	0.000347	0.0151	CbGeAlD
Pitavastatin—Nausea—Procarbazine—brain cancer	0.000342	0.00731	CcSEcCtD
Pitavastatin—SLCO2B1—central nervous system—brain cancer	0.000332	0.0145	CbGeAlD
Pitavastatin—Back pain—Etoposide—brain cancer	0.00033	0.00706	CcSEcCtD
Pitavastatin—Hypersensitivity—Hydroxyurea—brain cancer	0.000329	0.00702	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000328	0.00702	CcSEcCtD
Pitavastatin—Muscle spasms—Etoposide—brain cancer	0.000328	0.00702	CcSEcCtD
Pitavastatin—Insomnia—Carmustine—brain cancer	0.000326	0.00697	CcSEcCtD
Pitavastatin—SLCO2B1—cerebellum—brain cancer	0.000325	0.0142	CbGeAlD
Pitavastatin—Asthenia—Hydroxyurea—brain cancer	0.00032	0.00684	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000317	0.00678	CcSEcCtD
Pitavastatin—Ill-defined disorder—Etoposide—brain cancer	0.000317	0.00677	CcSEcCtD
Pitavastatin—ABCC2—endocrine gland—brain cancer	0.000316	0.0138	CbGeAlD
Pitavastatin—Insomnia—Temozolomide—brain cancer	0.000315	0.00673	CcSEcCtD
Pitavastatin—HMGCR—brain—brain cancer	0.000312	0.0136	CbGeAlD
Pitavastatin—Constipation—Carmustine—brain cancer	0.000308	0.00659	CcSEcCtD
Pitavastatin—Malaise—Etoposide—brain cancer	0.000308	0.00658	CcSEcCtD
Pitavastatin—Dyspepsia—Temozolomide—brain cancer	0.000307	0.00655	CcSEcCtD
Pitavastatin—CYP2C8—pituitary gland—brain cancer	0.000306	0.0133	CbGeAlD
Pitavastatin—Diarrhoea—Hydroxyurea—brain cancer	0.000305	0.00652	CcSEcCtD
Pitavastatin—Fatigue—Temozolomide—brain cancer	0.0003	0.00642	CcSEcCtD
Pitavastatin—Constipation—Temozolomide—brain cancer	0.000298	0.00637	CcSEcCtD
Pitavastatin—ABCG2—pituitary gland—brain cancer	0.000298	0.013	CbGeAlD
Pitavastatin—Feeling abnormal—Carmustine—brain cancer	0.000297	0.00635	CcSEcCtD
Pitavastatin—Dizziness—Hydroxyurea—brain cancer	0.000295	0.0063	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Carmustine—brain cancer	0.000295	0.0063	CcSEcCtD
Pitavastatin—ABCG2—medulla oblongata—brain cancer	0.000287	0.0125	CbGeAlD
Pitavastatin—Discomfort—Etoposide—brain cancer	0.000287	0.00614	CcSEcCtD
Pitavastatin—Feeling abnormal—Temozolomide—brain cancer	0.000287	0.00613	CcSEcCtD
Pitavastatin—Abdominal pain—Carmustine—brain cancer	0.000285	0.00609	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Temozolomide—brain cancer	0.000285	0.00609	CcSEcCtD
Pitavastatin—Rash—Hydroxyurea—brain cancer	0.000281	0.00601	CcSEcCtD
Pitavastatin—Confusional state—Etoposide—brain cancer	0.000281	0.00601	CcSEcCtD
Pitavastatin—Dermatitis—Hydroxyurea—brain cancer	0.000281	0.006	CcSEcCtD
Pitavastatin—Headache—Hydroxyurea—brain cancer	0.000279	0.00597	CcSEcCtD
Pitavastatin—Urticaria—Temozolomide—brain cancer	0.000277	0.00591	CcSEcCtD
Pitavastatin—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000277	0.0153	CbGpPWpGaD
Pitavastatin—Abdominal pain—Temozolomide—brain cancer	0.000275	0.00588	CcSEcCtD
Pitavastatin—Hypersensitivity—Carmustine—brain cancer	0.000266	0.00568	CcSEcCtD
Pitavastatin—Nausea—Hydroxyurea—brain cancer	0.000265	0.00566	CcSEcCtD
Pitavastatin—SLCO2B1—brain—brain cancer	0.000264	0.0115	CbGeAlD
Pitavastatin—ABCG2—midbrain—brain cancer	0.000263	0.0114	CbGeAlD
Pitavastatin—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.00026	0.0144	CbGpPWpGaD
Pitavastatin—Asthenia—Carmustine—brain cancer	0.000259	0.00553	CcSEcCtD
Pitavastatin—Hypersensitivity—Temozolomide—brain cancer	0.000257	0.00548	CcSEcCtD
Pitavastatin—ABCG2—spinal cord—brain cancer	0.000256	0.0112	CbGeAlD
Pitavastatin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000253	0.014	CbGpPWpGaD
Pitavastatin—Asthenia—Temozolomide—brain cancer	0.00025	0.00534	CcSEcCtD
Pitavastatin—Diarrhoea—Carmustine—brain cancer	0.000247	0.00527	CcSEcCtD
Pitavastatin—Pruritus—Temozolomide—brain cancer	0.000246	0.00527	CcSEcCtD
Pitavastatin—ALB—brain—brain cancer	0.000242	0.0105	CbGeAlD
Pitavastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000241	0.0133	CbGpPWpGaD
Pitavastatin—ABCG2—Irinotecan Pathway—APC—brain cancer	0.00024	0.0133	CbGpPWpGaD
Pitavastatin—Fatigue—Etoposide—brain cancer	0.00024	0.00514	CcSEcCtD
Pitavastatin—Dizziness—Carmustine—brain cancer	0.000238	0.00509	CcSEcCtD
Pitavastatin—Constipation—Etoposide—brain cancer	0.000238	0.00509	CcSEcCtD
Pitavastatin—Diarrhoea—Temozolomide—brain cancer	0.000238	0.00509	CcSEcCtD
Pitavastatin—CYP2C8—endocrine gland—brain cancer	0.000237	0.0103	CbGeAlD
Pitavastatin—Dizziness—Temozolomide—brain cancer	0.00023	0.00492	CcSEcCtD
Pitavastatin—Feeling abnormal—Etoposide—brain cancer	0.00023	0.00491	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Etoposide—brain cancer	0.000228	0.00487	CcSEcCtD
Pitavastatin—Rash—Carmustine—brain cancer	0.000227	0.00486	CcSEcCtD
Pitavastatin—Dermatitis—Carmustine—brain cancer	0.000227	0.00485	CcSEcCtD
Pitavastatin—Headache—Carmustine—brain cancer	0.000226	0.00483	CcSEcCtD
Pitavastatin—Urticaria—Etoposide—brain cancer	0.000221	0.00473	CcSEcCtD
Pitavastatin—Abdominal pain—Etoposide—brain cancer	0.00022	0.00471	CcSEcCtD
Pitavastatin—Rash—Temozolomide—brain cancer	0.00022	0.00469	CcSEcCtD
Pitavastatin—Dermatitis—Temozolomide—brain cancer	0.000219	0.00469	CcSEcCtD
Pitavastatin—Headache—Temozolomide—brain cancer	0.000218	0.00466	CcSEcCtD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000215	0.0119	CbGpPWpGaD
Pitavastatin—Nausea—Carmustine—brain cancer	0.000214	0.00458	CcSEcCtD
Pitavastatin—CYP2C9—endocrine gland—brain cancer	0.000211	0.00918	CbGeAlD
Pitavastatin—UGT1A3—Biological oxidations—CYP2C9—brain cancer	0.000208	0.0115	CbGpPWpGaD
Pitavastatin—Nausea—Temozolomide—brain cancer	0.000207	0.00442	CcSEcCtD
Pitavastatin—Hypersensitivity—Etoposide—brain cancer	0.000205	0.00439	CcSEcCtD
Pitavastatin—UGT1A3—Metapathway biotransformation—CYP2C9—brain cancer	0.000205	0.0114	CbGpPWpGaD
Pitavastatin—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000203	0.0113	CbGpPWpGaD
Pitavastatin—ABCG2—cerebellum—brain cancer	0.000203	0.00885	CbGeAlD
Pitavastatin—Asthenia—Etoposide—brain cancer	0.0002	0.00427	CcSEcCtD
Pitavastatin—HMGCR—SREBP signalling—SIRT1—brain cancer	0.000197	0.0109	CbGpPWpGaD
Pitavastatin—Pruritus—Etoposide—brain cancer	0.000197	0.00421	CcSEcCtD
Pitavastatin—Diarrhoea—Etoposide—brain cancer	0.000191	0.00408	CcSEcCtD
Pitavastatin—Dizziness—Etoposide—brain cancer	0.000184	0.00394	CcSEcCtD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000182	0.0101	CbGpPWpGaD
Pitavastatin—ABCB1—telencephalon—brain cancer	0.00018	0.00786	CbGeAlD
Pitavastatin—UGT2B7—Biological oxidations—CYP2C9—brain cancer	0.000177	0.00979	CbGpPWpGaD
Pitavastatin—Rash—Etoposide—brain cancer	0.000176	0.00376	CcSEcCtD
Pitavastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000176	0.00972	CbGpPWpGaD
Pitavastatin—Dermatitis—Etoposide—brain cancer	0.000176	0.00375	CcSEcCtD
Pitavastatin—Headache—Etoposide—brain cancer	0.000175	0.00373	CcSEcCtD
Pitavastatin—UGT2B7—Metapathway biotransformation—CYP2C9—brain cancer	0.000174	0.00965	CbGpPWpGaD
Pitavastatin—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000173	0.0096	CbGpPWpGaD
Pitavastatin—CYP2C8—brain—brain cancer	0.00017	0.00739	CbGeAlD
Pitavastatin—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000166	0.00919	CbGpPWpGaD
Pitavastatin—Nausea—Etoposide—brain cancer	0.000166	0.00354	CcSEcCtD
Pitavastatin—ABCG2—brain—brain cancer	0.000165	0.00719	CbGeAlD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000163	0.009	CbGpPWpGaD
Pitavastatin—ABCB1—gonad—brain cancer	0.00015	0.00656	CbGeAlD
Pitavastatin—ABCB1—pituitary gland—brain cancer	0.000147	0.0064	CbGeAlD
Pitavastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000142	0.00788	CbGpPWpGaD
Pitavastatin—ABCB1—medulla oblongata—brain cancer	0.000142	0.00617	CbGeAlD
Pitavastatin—HMGCR—AMPK Signaling—PIK3CG—brain cancer	0.00014	0.00777	CbGpPWpGaD
Pitavastatin—ABCB1—midbrain—brain cancer	0.000129	0.00564	CbGeAlD
Pitavastatin—ABCB1—spinal cord—brain cancer	0.000126	0.0055	CbGeAlD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00012	0.00665	CbGpPWpGaD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000114	0.0063	CbGpPWpGaD
Pitavastatin—ABCB1—endocrine gland—brain cancer	0.000114	0.00496	CbGeAlD
Pitavastatin—ABCB1—head—brain cancer	0.000112	0.00489	CbGeAlD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000111	0.00617	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000111	0.00612	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000108	0.00595	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000105	0.00584	CbGpPWpGaD
Pitavastatin—ABCB1—central nervous system—brain cancer	0.000102	0.00447	CbGeAlD
Pitavastatin—ABCB1—cerebellum—brain cancer	0.0001	0.00436	CbGeAlD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	9.86e-05	0.00546	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.8e-05	0.00542	CbGpPWpGaD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	8.79e-05	0.00486	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.79e-05	0.00486	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—S100A10—brain cancer	8.64e-05	0.00478	CbGpPWpGaD
Pitavastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	8.52e-05	0.00472	CbGpPWpGaD
Pitavastatin—ABCB1—brain—brain cancer	8.14e-05	0.00355	CbGeAlD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CDK4—brain cancer	7.97e-05	0.00441	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	7.75e-05	0.00429	CbGpPWpGaD
Pitavastatin—CYP2C8—Biological oxidations—CYP2C9—brain cancer	7.57e-05	0.00419	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.53e-05	0.00416	CbGpPWpGaD
Pitavastatin—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	7.46e-05	0.00413	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.16e-05	0.00396	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	7.13e-05	0.00395	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	7.07e-05	0.00391	CbGpPWpGaD
Pitavastatin—HMGCR—AMPK Signaling—TP53—brain cancer	6.35e-05	0.00351	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	6.18e-05	0.00342	CbGpPWpGaD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	6.16e-05	0.00341	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—SOD2—brain cancer	5.8e-05	0.00321	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	5.8e-05	0.00321	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.5e-05	0.00305	CbGpPWpGaD
Pitavastatin—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	5.47e-05	0.00303	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	5.37e-05	0.00297	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CYP2C9—brain cancer	5.35e-05	0.00296	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—brain cancer	5.15e-05	0.00285	CbGpPWpGaD
Pitavastatin—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.11e-05	0.00283	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	5.1e-05	0.00282	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.06e-05	0.0028	CbGpPWpGaD
Pitavastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.86e-05	0.00269	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—SOD2—brain cancer	4.61e-05	0.00255	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—BSG—brain cancer	4.55e-05	0.00252	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	4.49e-05	0.00248	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CYP2C9—brain cancer	4.36e-05	0.00241	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	4.2e-05	0.00232	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	4.16e-05	0.0023	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—brain cancer	4.13e-05	0.00229	CbGpPWpGaD
Pitavastatin—ALB—Vitamin B12 Metabolism—RELA—brain cancer	4.12e-05	0.00228	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—brain cancer	4.04e-05	0.00224	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—MPL—brain cancer	3.99e-05	0.00221	CbGpPWpGaD
Pitavastatin—SLCO1B3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.99e-05	0.00221	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—IDH1—brain cancer	3.91e-05	0.00217	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—S100A10—brain cancer	3.83e-05	0.00212	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—BSG—brain cancer	3.71e-05	0.00205	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.7e-05	0.00205	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP2C9—brain cancer	3.56e-05	0.00197	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.5e-05	0.00194	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	3.43e-05	0.0019	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—brain cancer	3.39e-05	0.00188	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—RELA—brain cancer	3.35e-05	0.00186	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP2C9—brain cancer	3.35e-05	0.00185	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	3.32e-05	0.00184	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	3.32e-05	0.00183	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—IDH1—brain cancer	3.19e-05	0.00177	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.19e-05	0.00176	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—ENO2—brain cancer	3.09e-05	0.00171	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP2C9—brain cancer	3.02e-05	0.00167	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—BSG—brain cancer	3.02e-05	0.00167	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—IL2—brain cancer	3.02e-05	0.00167	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.91e-05	0.00161	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	2.9e-05	0.00161	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.89e-05	0.0016	CbGpPWpGaD
Pitavastatin—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.85e-05	0.00158	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—BSG—brain cancer	2.85e-05	0.00158	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.8e-05	0.00155	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—BSG—brain cancer	2.7e-05	0.00149	CbGpPWpGaD
Pitavastatin—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.68e-05	0.00148	CbGpPWpGaD
Pitavastatin—ALB—Selenium Micronutrient Network—RELA—brain cancer	2.66e-05	0.00147	CbGpPWpGaD
Pitavastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.63e-05	0.00145	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—IDH1—brain cancer	2.6e-05	0.00144	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.6e-05	0.00144	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—BSG—brain cancer	2.57e-05	0.00142	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	2.57e-05	0.00142	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—ENO2—brain cancer	2.52e-05	0.0014	CbGpPWpGaD
Pitavastatin—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.48e-05	0.00137	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—IDH1—brain cancer	2.45e-05	0.00136	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.3e-05	0.00127	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—IL2—brain cancer	2.29e-05	0.00127	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.26e-05	0.00125	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP2C9—brain cancer	2.25e-05	0.00125	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.25e-05	0.00124	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.23e-05	0.00123	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—IDH1—brain cancer	2.21e-05	0.00122	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—VEGFA—brain cancer	2.2e-05	0.00122	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.12e-05	0.00118	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.11e-05	0.00117	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	2.1e-05	0.00116	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP2C9—brain cancer	2.09e-05	0.00115	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.07e-05	0.00115	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—ENO2—brain cancer	2.06e-05	0.00114	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2e-05	0.0011	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.98e-05	0.00109	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.95e-05	0.00108	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TP53—brain cancer	1.94e-05	0.00107	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—ENO2—brain cancer	1.94e-05	0.00107	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—BSG—brain cancer	1.91e-05	0.00106	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—BSG—brain cancer	1.77e-05	0.000981	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TRPC6—brain cancer	1.77e-05	0.000979	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ENO2—brain cancer	1.75e-05	0.000967	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.73e-05	0.000957	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.71e-05	0.000945	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—IDH1—brain cancer	1.65e-05	0.000911	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.63e-05	0.000903	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.61e-05	0.000889	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	1.53e-05	0.000847	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—IDH1—brain cancer	1.52e-05	0.000844	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CG—brain cancer	1.42e-05	0.000785	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.34e-05	0.000742	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.34e-05	0.000742	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VAV1—brain cancer	1.33e-05	0.000733	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ENO2—brain cancer	1.3e-05	0.00072	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP2C9—brain cancer	1.29e-05	0.000716	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP2C9—brain cancer	1.29e-05	0.000712	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.25e-05	0.000691	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ENO2—brain cancer	1.21e-05	0.000667	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CG—brain cancer	1.16e-05	0.00064	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.15e-05	0.000636	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP2C9—brain cancer	1.13e-05	0.000624	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.1e-05	0.00061	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—BSG—brain cancer	1.1e-05	0.000609	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—BSG—brain cancer	1.09e-05	0.000605	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.09e-05	0.000604	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	9.76e-06	0.00054	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.61e-06	0.000532	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—BSG—brain cancer	9.59e-06	0.00053	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—IDH1—brain cancer	9.46e-06	0.000524	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CG—brain cancer	9.43e-06	0.000522	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—IDH1—brain cancer	9.41e-06	0.000521	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—BSG—brain cancer	8.95e-06	0.000496	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CG—brain cancer	8.89e-06	0.000492	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.84e-06	0.000489	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.65e-06	0.000479	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CG—brain cancer	8.41e-06	0.000466	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—IDH1—brain cancer	8.24e-06	0.000456	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CG—brain cancer	8.02e-06	0.000444	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.7e-06	0.000426	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—IDH1—brain cancer	7.7e-06	0.000426	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.66e-06	0.000424	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ENO2—brain cancer	7.48e-06	0.000414	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ENO2—brain cancer	7.44e-06	0.000412	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.26e-06	0.000402	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ENO2—brain cancer	6.52e-06	0.000361	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.27e-06	0.000347	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ENO2—brain cancer	6.09e-06	0.000337	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CG—brain cancer	5.97e-06	0.00033	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IL2—brain cancer	5.92e-06	0.000328	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CG—brain cancer	5.53e-06	0.000306	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—brain cancer	5.03e-06	0.000278	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—brain cancer	3.8e-06	0.00021	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CG—brain cancer	3.43e-06	0.00019	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CG—brain cancer	3.41e-06	0.000189	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CG—brain cancer	2.99e-06	0.000165	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CG—brain cancer	2.79e-06	0.000155	CbGpPWpGaD
